Evidence map›Paper›PMID 38045118›Full record

ArticleHeliyon2023

Sickle cell disease classification using deep learning.

Sanjeda Sara Jennifer, Mahbub Hasan Shamim, Ahmed Wasif Reza, Nazmul Siddique

Abstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sanjeda Sara JenniferDepartment of Computer Science and Engineering, East West University, Dhaka, Bangladesh.
Mahbub Hasan ShamimDepartment of Computer Science and Engineering, East West University, Dhaka, Bangladesh.
Ahmed Wasif RezaDepartment of Computer Science and Engineering, East West University, Dhaka, Bangladesh.
Nazmul SiddiqueSchool of Computing, Engineering and Intelligent Systems, Ulster University, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper presents a transfer and deep learning based approach to the classification of Sickle Cell Disease (SCD). Five transfer learning models such as ResNet-50, AlexNet, MobileNet, VGG-16 and VGG-19, and a sequential convolutional neural network (CNN) have been implemented for SCD classification. ErythrocytesIDB dataset has been used for training and testing the models. In order to make up for the data insufficiency of the erythrocytesIDB dataset, advanced image augmentation techniques are employed to ensure the robustness of the dataset, enhance dataset diversity and improve the accuracy of the models. An ablation experiment using Random Forest and Support Vector Machine (SVM) classifiers along with various hyperparameter tweaking was carried out to determine the contribution of different model elements on their predicted accuracy. A rigorous statistical analysis was carried out for evaluation and to further evaluate the model's robustness, an adversarial attack test was conducted. The experimental results demonstrate compelling performance across all models. After performing the statistical tests, it was observed that MobileNet showed a significant improvement (p = 0.0229), while other models (ResNet-50, AlexNet, VGG-16, VGG-19) did not (p > 0.05). Notably, the ResNet-50 model achieves remarkable precision, recall, and F1-score values of 100 % for circular, elongated, and other cell shapes when experimented with a smaller dataset. The AlexNet model achieves a balanced precision (98 %) and recall (99 %) for circular and elongated shapes. Meanwhile, the other models showcase competitive performance.

Indexed as

Ablation experimentClassificationDeep learning modelMachine learning classifierSickle cell disease

Identifiers

PMID38045118
PMCPMC10692811

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.